tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Income Statement

Compare
230 Followers

GT Biopharma Income Statement

Last quarter (Q4 2024), GT Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, GT Biopharma's net income was $-3.77M. See GT Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.36M$ 13.58M$ 21.26M$ 57.52M$ 6.76M
Depreciation and Amortization
$ 0.00$ 13.58M$ 21.26M$ 57.52M$ 4.00K
EBITDA
$ -14.36M$ 5.98M$ 0.00$ 0.00$ -24.98M
Operating Income
$ -14.36M$ -13.58M$ -21.26M$ -57.52M$ -6.76M
Other Income/Expenses
$ 1.20M$ 5.98M$ 373.00K$ -498.00K$ -21.53M
Pretax Income
$ -13.16M$ -7.60M$ -20.88M$ -58.01M$ -28.30M
Net Income
$ -13.16M$ -7.60M$ -20.50M$ -58.69M$ -31.62M
Per Share Metrics
Basic EPS
$ -6.94$ -5.64$ -19.30$ -62.54$ -216.29
Diluted EPS
$ -6.94$ -5.64$ -19.30$ -62.54$ -216.29
Weighted Average Shares Outstanding
1.90M 1.35M 1.06M 938.52K 146.17K
Weighted Average Shares Outstanding (Diluted)
1.90M 1.35M 1.06M 938.52K 146.17K
Currency in USD

GT Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis